Wells Fargo
MXCT icon

Wells Fargo’s MaxCyte MXCT Stock Holding History

Wells Fargo’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.8K Sell
38,214
-75,167
-66% -$70.2K ﹤0.01% 5674
2025
Q4 		$176K Buy
113,381
+35,845
+46% +$57.3K ﹤0.01% 5140
2025
Q3 		$123K Buy
77,536
+12,642
+19% +$22K ﹤0.01% 5213
2025
Q2 		$141K Buy
64,894
+1,379
+2% +$3.34K ﹤0.01% 4978
2025
Q1 		$173K Buy
63,515
+2,104
+3% +$8.29K ﹤0.01% 4803
2024
Q4 		$255K Buy
61,411
+13,376
+28% +$50.6K ﹤0.01% 4646
2024
Q3 		$187K Buy
48,035
+2,064
+4% +$8.7K ﹤0.01% 4630
2024
Q2 		$180K Buy
45,971
+15,285
+50% +$65.8K ﹤0.01% 4578
2024
Q1 		$129K Buy
30,686
+3,933
+15% +$18.5K ﹤0.01% 4747
2023
Q4 		$126K Buy
26,753
+5,312
+25% +$20.7K ﹤0.01% 4767
2023
Q3 		$66.9K Sell
21,441
-12,117
-36% -$48.7K ﹤0.01% 5020
2023
Q2 		$154K Buy
33,558
+17,858
+114% +$82.1K ﹤0.01% 4749
2023
Q1 		$77.7K Buy
15,700
+15,686
+112,043% +$77.2K ﹤0.01% 4944
2022
Q4 		$76 Sell
14
-225
-94% -$1.38K ﹤0.01% 6864
2022
Q3 		$2K Sell
239
-285
-54% -$1.59K ﹤0.01% 6167
2022
Q2 		$2K Sell
524
-91,541
-99% -$451K ﹤0.01% 6347
2022
Q1 		$644K Sell
92,065
-6,034
-6% -$41.2K ﹤0.01% 4227
2021
Q4 		$1M Sell
98,099
-89,556
-48% -$962K ﹤0.01% 4105
2021
Q3 		$2.29M Buy
+187,655
New +$2.83M ﹤0.01% 3540

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Wells Fargo's MXCT Position: Q1 2026 in Review

Wells Fargo reduced its MaxCyte (MXCT) stake by 66% in Q1 2026, selling an estimated $70.2K and leaving 38,214 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5674.

Wells Fargo first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.29M in Q3 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Wells Fargo held 38,214 shares of MaxCyte worth $26.8K as of Q1 2026.
  • Wells Fargo sold 75,167 MaxCyte shares in Q1 2026, an estimated $70.2K.
  • MaxCyte made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5674 holding.
  • Wells Fargo first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Wells Fargo's MaxCyte position peaked at $2.29M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.